Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Leila Rahbarnia, Safar Farajnia, Hossein Babaei, Jafar Majidi, Kamal Veisi, Vahideh Ahmadzadeh & Bahman Akbari. (2017) Evolution of phage display technology: from discovery to application. Journal of Drug Targeting 25:3, pages 216-224.
Read now
Read now
Atish Prakash, Jaspreet Kalra, Vasudevan Mani, Kalavathy Ramasamy & Abu Bakar Abdul Majeed. (2015) Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets. Expert Review of Neurotherapeutics 15:1, pages 53-71.
Read now
Read now
Giulia Paroni, Davide Seripa, Andrea Fontana, Grazia D’Onofrio, Carolina Gravina, Maria Urbano, Leandro Cascavilla, Fabio Pellegrini, Antonio Greco & Alberto Pilotto. (2014) FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease. Clinical Interventions in Aging 9, pages 1783-1791.
Read now
Read now
Haythum O Tayeb, Evan D Murray, Bruce H Price & Frank I Tarazi. (2013) Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?. Expert Opinion on Biological Therapy 13:7, pages 1075-1084.
Read now
Read now
Bruno P Imbimbo, Simone Ottonello, Vincenza Frisardi, Vincenzo Solfrizzi, Antonio Greco, Davide Seripa, Alberto Pilotto & Francesco Panza. (2012) Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease. Expert Review of Clinical Immunology 8:2, pages 135-149.
Read now
Read now
Articles from other publishers (28)
Michael Kunle Ajenikoko, Abayomi Oyeyemi Ajagbe, Oluwanisola Akanji Onigbinde, Akeem Ayodeji Okesina & Ahmad Adekilekun Tijani. (2023) Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction. IBRO Neuroscience Reports 14, pages 64-76.
Crossref
Crossref
Li-Feng-Rong Qi, Shuai Liu, Yu-Ci Liu, Ping Li & Xiaojun Xu. (2021) Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) through Autophagy Induced by Activating Axl. International Journal of Molecular Sciences 22:11, pages 5559.
Crossref
Crossref
Hari Shanker Sharma, Dafin F. Muresanu, Ala Nozari, José Vicente Lafuente, Anca D. Buzoianu, Seaab Sahib, Z. Ryan Tian, Igor Bryukhovetskiy, Igor Manzhulo, Preeti K. Menon, Ranjana Patnaik, Lars Wiklund & Aruna Sharma. 2021. Nanomedicine and Neuroprotection in Brain Diseases. Nanomedicine and Neuroprotection in Brain Diseases
1
97
.
Alejandro R. Roda, Gisela Esquerda-Canals, Joaquim Martí-Clúa & Sandra Villegas. (2020) Cognitive Impairment in the 3xTg-AD Mouse Model of Alzheimer’s Disease is Affected by Aβ-ImmunoTherapy and Cognitive Stimulation. Pharmaceutics 12:10, pages 944.
Crossref
Crossref
Alejandro R. Roda, Laia Montoliu-Gaya, Gabriel Serra-Mir & Sandra Villegas. (2020) Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice. International Journal of Molecular Sciences 21:18, pages 6630.
Crossref
Crossref
Greet B.A. Teuns. 2020. Information Resources in Toxicology. Information Resources in Toxicology
513
520
.
R. Loera‐Valencia, A. Cedazo‐Minguez, P.A. Kenigsberg, G. Page, A.I. Duarte, P. Giusti, M. Zusso, P. Robert, G. B. Frisoni, Annamaria Cattaneo, M. Zille, J. Boltze, N. Cartier, L. Buee, G. Johansson & B. Winblad. (2019) Current and emerging avenues for Alzheimer's disease drug targets. Journal of Internal Medicine 286:4, pages 398-437.
Crossref
Crossref
Matthew Macaluso, Michael Krams, Jonathan Savitz, Wayne C. Drevets & Sheldon H. Preskorn. 2019. Translational Medicine in CNS Drug Development. Translational Medicine in CNS Drug Development
81
91
.
Randall J. Bateman, Tammie L. Benzinger, Scott Berry, David B. Clifford, Cynthia Duggan, Anne M. Fagan, Kathleen Fanning, Martin R. Farlow, Jason Hassenstab, Eric M. McDade, Susan Mills, Katrina Paumier, Melanie Quintana, Stephen P. Salloway, Anna Santacruz, Lon S. Schneider, Guoqiao Wang & Chengjie Xiong. (2016) The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model. Alzheimer's & Dementia 13:1, pages 8-19.
Crossref
Crossref
R. Bartha & T.-Y. Lee. 2017. The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders. The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders
57
80
.
Hanna Lindberg, Torleif Härd, John Löfblom & Stefan Ståhl. (2015) A truncated and dimeric format of an Affibody library on bacteria enables FACS‐mediated isolation of amyloid‐beta aggregation inhibitors with subnanomolar affinity. Biotechnology Journal 10:11, pages 1707-1718.
Crossref
Crossref
Greet Teuns. 2015. Nonclinical Assessment of Abuse Potential for New Pharmaceuticals. Nonclinical Assessment of Abuse Potential for New Pharmaceuticals
101
127
.
Javier Olazarán, Ana Ramos, Inmaculada Boyano, Eva Alfayate, Meritxell Valentí, Alberto Rábano & Juan Álvarez-Linera. (2014) Pattern of and Risk Factors for Brain Microbleeds in Neurodegenerative Dementia. American Journal of Alzheimer's Disease & Other Dementiasr 29:3, pages 263-269.
Crossref
Crossref
Jian-Ming Li, Zhi-Qin Xue, Si-Hao Deng, Xue-Gang Luo, Peter R. Patrylo, Gregory W. Rose, Huaibin Cai, Yan Cai & Xiao-Xin Yan. (2012) Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury. Neurotoxicity Research 24:1, pages 1-14.
Crossref
Crossref
Massimo Stefani & Stefania Rigacci. (2013) Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds. International Journal of Molecular Sciences 14:6, pages 12411-12457.
Crossref
Crossref
John G. Elvin, Ruairidh G. Couston & Christopher F. van der Walle. (2013) Therapeutic antibodies: Market considerations, disease targets and bioprocessing. International Journal of Pharmaceutics 440:1, pages 83-98.
Crossref
Crossref
Juan E. Gutierrez, Brian Eichinger & Kejal Kantarci. 2013. Evidence-Based Neuroimaging Diagnosis and Treatment. Evidence-Based Neuroimaging Diagnosis and Treatment
283
298
.
Elaine L Bearer. (2012)
HSV, axonal transport and Alzheimer’s disease:
in vitro
and
in vivo
evidence for causal relationships
. Future Virology 7:9, pages 885-899.
Crossref
Crossref
Zhongqiu Luo, Jialin Li, Neel R. Nabar, Xiaoyang Lin, Ge Bai, Jianfeng Cai, Shu-Feng Zhou, Chuanhai Cao & Jinhuan Wang. (2012) Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice. Journal of Neuroimmune Pharmacology 7:3, pages 640-655.
Crossref
Crossref
Francesco PanzaVincenza Frisardi, Bruno P Imbimbo, Giancarlo Logroscino, Davide Seripa, Alberto Pilotto & Vincenzo Solfrizzi. (2012) Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer’s disease patients. Future Neurology 7:4, pages 395-401.
Crossref
Crossref
Matthew Macaluso, Michael Krams & Sheldon Preskorn. 2012. Essential CNS Drug Development. Essential CNS Drug Development
55
69
.
James E Galvin. (2012) Optimizing diagnosis and management in mild-to-moderate Alzheimer’s disease. Neurodegenerative Disease Management 2:3, pages 291-304.
Crossref
Crossref
Haythum O. Tayeb, Hyun Duk Yang, Bruce H. Price & Frank I. Tarazi. (2012) Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors. Pharmacology & Therapeutics 134:1, pages 8-25.
Crossref
Crossref
Francesco PanzaVincenza Frisardi, Vincenzo Solfrizzi, Bruno P Imbimbo, Giancarlo Logroscino, Andrea Santamato, Antonio Greco, Davide Seripa & Alberto Pilotto. (2012) Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy 4:2, pages 213-238.
Crossref
Crossref
Harrie J.M. Gijsen & François P. Bischoff. 2012. Annual Reports in Medicinal Chemistry Volume 47. Annual Reports in Medicinal Chemistry Volume 47
55
69
.
Philip Seeman & Neil Seeman. (2011) Alzheimer's disease: ?-amyloid plaque formation in human brain. Synapse 65:12, pages 1289-1297.
Crossref
Crossref
Ramit Ravona-Springer & Amos D Korczyn. (2011) Current conceptions of the etiology and risk factors for Alzheimer’s disease and their possible implications on the design of dementia clinical trials. Clinical Investigation 1:11, pages 1491-1503.
Crossref
Crossref
G. Puras, A. Salvador, M. Igartua, R.M. Hernández & J.L. Pedraz. (2011) Encapsulation of Aβ1–15 in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes. European Journal of Pharmaceutical Sciences 44:3, pages 200-206.
Crossref
Crossref